- Research article
- Open Access
Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points
Neural Development volume 3, Article number: 34 (2008)
The trajectory of corticospinal tract (CST) axons from cortex to spinal cord involves a succession of choice points, each of which is controlled by multiple guidance molecules. To assess the involvement of transmembrane semaphorins and their plexin receptors in the guidance of CST axons, we have examined this tract in mutants of Semaphorin-6A (Sema6A), Plexin-A2 (PlxnA2) and Plexin-A4 (PlxnA4).
We describe defects in CST guidance in Sema6A mutants at choice points at the mid-hindbrain boundary (MHB) and in navigation through the pons that dramatically affect how many axons arrive to the hindbrain and spinal cord and result in hypoplasia of the CST. We also observe defects in guidance within the hindbrain where a proportion of axons aberrantly adopt a ventrolateral position and fail to decussate. This function in the hindbrain seems to be mediated by the known Sema6A receptor PlxnA4, which is expressed by CST axons. Guidance at the MHB, however, appears independent of this and of the other known receptor, PlxnA2, and may depend instead on Sema6A expression on CST axons themselves at embryonic stages.
These data identify Sema6A as a major contributor to the guidance of CST axons at multiple choice points. They highlight the active control of guidance at the MHB and also implicate the inferior olive as an important structure in the guidance of CST axons within the hindbrain. They also suggest that Sema6A, which is strongly expressed by oligodendrocytes, may affect CST regeneration in adults.
The corticospinal tract (CST) is a well-defined model system for several neurodevelopmental processes, such as axon guidance, topographic connectivity, collateral sprouting and stereotyped pruning, which establish precise patterns of connectivity in the vertebrate nervous system . The trajectory of the CST from the cortex to the spinal cord involves a succession of choice points (Figure 1), each of which is controlled independently, often by different sets of molecules (comprehensively reviewed in ).
Genetic analyses have revealed a number of specific choice points that are particularly vulnerable to genetic lesions, most probably because they involve sudden deviations in trajectory, crossing borders between embryonic compartments or departure from larger nerve pathways. For example, defects in the guidance of corticofugal projections, including CST axons, have been observed in various mutants in the initial projections from the cortex across the pallial-subpallial boundary (Celsr3 [2, 3], Frizzled-3 [4, 5], Pax6 ), within the internal capsule (Ctip2 ) and across the telencephalic-diencephalic border into the cerebral peduncles (Nkx2-1 , Slits , Robos ). Ctip2 mutants also display defects in CST projections more caudally, at the level of the pons . A number of other mutants cause defects in CST projections in the hindbrain, especially at the junction of the medulla and spinal cord, where they form the pyramidal decussation. At this point, CST axons, which have been extending caudally in a ventral position near the midline, project dorsally and across the midline (forming an X, hence 'decus', from the Roman numeral) to join the dorsal funiculus, where they resume their caudal course. A variety of defects in CST projections at this region are observed in mutants of L1CAM [11–13], EphA4 [14–18], NCAM , and netrin-1 or netrin receptor genes . Such defects are often, though not always, associated with hypoplasia of the CST, presumably due to secondary degeneration of mistargeted axons.
Understanding the molecular control of CST guidance is of clinical importance in two ways. First, a number of hereditary neurological disorders involve aberrant development and/or progressive degeneration of the CST, which generally results in spastic paraplegia [21, 22]. For example, in L1 syndrome, caused by mutations in L1CAM , spasticity is due to CST hypoplasia, which is probably a result of a CST guidance defect at the pyramidal decussation, as seen in L1-deficient mice [11–13, 24]. Joubert syndrome, which can be caused by mutations in five known genes [25, 26], is also characterised by a failure of CST axons to decussate normally [27–31]. In addition, a recent study suggests that CST development may be compromised in adolescent-onset schizophrenia, which commonly involves motor symptoms . Second, the elucidation of the developmental programme controlling CST axon guidance is highly relevant to the development of strategies to promote regeneration of spinal nerves following injury or degeneration . Thus, guidance molecules with known functions in CST development have later been reported to improve CST regeneration after their manipulation in animal models for spinal cord injury, including L1 [34–36] and EphA4 .
Semaphorins have been implicated in the control of multiple aspects of neural development, including cell migration, axon guidance, dendritogenesis and many others [38, 39]. Though secreted class 3 semaphorins have been better studied, transmembrane semaphorins, especially of class 6, have attracted recent interest with the discoveries that they are important mediators in vivo of axon guidance and cell migration in many different parts of the brain [18, 40–44]. These functions seem to be mediated by direct and specific binding to members of the PlxnA subfamily [40, 41, 45, 46]. There is good evidence that these transmembrane semaphorins and their invertebrate orthologues can also function as receptors [47–51]. Analyses of Sema6A mutants have highlighted the important role of this molecule in cell migration and axon guidance in many parts of the nervous system [18, 42, 44, 45] and the complicated, context-dependent nature of its interactions with PlxnA2 and PlxnA4 [42, 43, 45, 52].
Here, we identify defects in CST axon guidance in Sema6A mutants at the mid-hindbrain boundary (MHB) and in navigation over the pontine nuclei that dramatically affect how many axons arrive to the hindbrain and spinal cord. We also observe defects in the caudal medulla where many axons spread laterally, resulting in a failure to decussate. The latter role seems to be mediated by the known Sema6A receptor PlxnA4, but the former appears independent of this and of the other known receptor, PlxnA2, and may depend on early expression of Sema6A on CST axons themselves. These data identify Sema6A as a major contributor to the guidance of CST axons at multiple choice points.
Hypoplasia and misrouting of the corticospinal tract in adult Sema6A mutants
Mutants in Sema6A were generated in a gene trap screen and have been previously described [18, 53]. Macroscopic examination of the hindbrains of adult Sema6A mutants (n = 9) in comparison with wild-type (n = 3) and Sema6A heterozygous mice (n = 12) revealed dramatic defects in the size and trajectory of the CST. This tract was visible in wild-type and Sema6A+/- mice as a highly myelinated tract running at the ventral surface of the medulla (Figure 2a). In contrast, in many Sema6A mutants (four out of nine) the CST was not visible as the medullar pyramids macroscopically (Figure 2b). In other mutants (five out of nine), the pyramids remained visible macroscopically, that is, they appeared as a tight bundle at the surface, but their size was reduced to various degrees between animals as well as between pyramids on either side of individuals (Figure 2c).
We used staining for the reporter gene placental alkaline phosphatase (PLAP), which is encoded on the gene trap cassette inserted into the Sema6A locus , to examine the CST of adult Sema6A+/- and Sema6A-/- mice at a microscopic level (Figure 2d–l). In adults, Sema6A, and thus PLAP, is strongly expressed in oligodendrocytes. Therefore, staining for PLAP labels all myelinated fibres in adults with one or both mutant alleles. The stainings confirmed a wide range in severity of CST size reduction and showed a reasonably smooth distribution in severity across the mutants analysed, including those that had no macroscopically visible CST. In addition, PLAP stainings revealed defects of the remaining CST axons. Instead of running at the surface of the medulla as a tightly fasciculated bundle as seen in Sema6A+/- mice (Figure 2d, g, j), they were often split into several bundles that ran either normally at the surface (Figure 2f) or aberrantly deeper within the medulla (that is, at the rostrocaudal level of the inferior olive, they are embedded within the olive; Figure 2e, arrowhead). More strikingly, at the caudal olive a variable proportion of the remaining CST axons projected away from the midline towards the ventrolateral spinal cord (Figure 2i; but also detectable macroscopically when the CST remained visible at the surface, Figure 2c, arrowheads). Such axons failed to decussate and instead proceeded down the spinal cord in a ventrolateral position (Figure 2l, asterisk). The small portion of CST axons that remained close to the midline decussated correctly and entered the dorsal funiculus of the spinal cord (Figure 2h, k).
Corticospinal tract guidance defects at earlier choice points
The hypoplasia of the CST might be the result of a guidance defect at the pyramidal decussation with many axons dying because they do not find their targets, while others manage to contact their targets even after misguidance and via an alternative route. Another possibility is that hypoplasia of the tract at the level of the medulla is due to fewer axons reaching that point in the first place; that is, that there is an additional choice point along the CST trajectory at which axons are misguided and fail to proceed down the spinal cord. To test these ideas we traced the CST during its development, that is, at postnatal day (P)4, when the majority of CST axons have just arrived in the spinal cord.
Placement of small crystals of the lipophilic dye DiI into the motor cortex of P4 post-mortem brains effectively labelled the descending CST (Figure 3). In Sema6A+/- mice (n = 4; Figure 3, left column), traced fibres could be followed through the internal capsule and cerebral peduncle, revealing the normal trajectory of these fibres through the brain. At the MHB, traced fibres extending longitudinally on the ventrolateral surface of the midbrain turn medially and travel halfway towards the midline, then turn ventrally over the pontine nucleus to finally reach the ventral surface of the medulla to form the pyramids.
In Sema6A mutants (n = 5) we did not observe major trajectory defects of traced axons rostral to the MHB and the gross amount of traced fibres immediately rostral to the MHB was comparable to that seen in Sem6A heterozygous mice (data not shown; Figure 3a, b). However, at the MHB of Sema6A mutant mice (Figure 3, middle and right columns) we observed traced fibres taking several aberrant routes. At the caudal midbrain, most axons initially made a correct medial turn but some turned dorsally instead (three of five; Figure 3b, e, f, blue arrowheads). Of the axons that turned medially, a large fraction failed to turn ventrally over the pontine nuclei and instead projected all the way to the midline (five of five) and even crossed it (four of five), below the interpeduncular nucleus (four of five), or, as a minor fraction, turned dorsally (three of five; Figure 3b, yellow or green arrowheads, respectively) or ventrally (two of five). In the ventral projection over the pontine nuclei the tract appeared split into a couple of bundles. Some axons ran correctly close to the midline but others could be found to split from this main bundle to take an aberrant route within the pons or towards lateral areas (three of five; Figure 3e, f, h, i, pink arrowheads).
Further caudally, in Sema6A+/- mice, traced fibres travelled through the medulla close to the midline (Figure 3j). This could also be observed for the reduced amount (to varying degrees) of axons that were routed properly at the MHB of Sema6A mutants (Figure 3k, l). However, at the level of the inferior olive, which appeared to form normally in Sema6A mutants, some (two of four) or all (two of four) of these axons projected away from the midline and were some distance away from the spot where CST axons of wild-type mice would turn dorsally and cross the midline (Figure 3n, o). These axons proceeded ipsilaterally at a ventrolateral position.
Expression of Sema6A and its interacting partners
Sema6A is known to mediate some effects through interactions with PlxnA2 [42, 52] and/or PlxnA4 [40, 45]. Some members of this class of transmembrane semaphorins or their orthologues in invertebrates have also been shown to be capable of reverse signalling, presumably as receptors [47–51]. To assess whether these plexin proteins might be involved in mediating these functions of Sema6A and/or whether Sema6A might be acting cell-autonomously in CST axons, we examined the expression patterns of these genes in motor cortex and in the regions of the midbrain and hindbrain where defects are observed.
We used reporter gene staining, RNA in situ hybridization and immunohistochemistry to examine Sema6A expression, which we found to be highly dynamic. At embryonic day (E)17.5, CST axons have crossed the mid-hindbrain border and reached the pons. At this stage, CST axons stain positively for PLAP in Sema6A gene trap embryos (Figure 4a, a'). This is far prior to the onset of myelination, demonstrating that neurons that give rise to the CST normally express Sema6A in late embryogenesis. To examine the distribution of the Sema6A protein itself, we performed immunohistochemistry on sections from E17.5 and P1 brains, using a commercially available polyclonal antibody against murine Sema6A (Figure 4b–q), which we proved to be specific for Sema6A by comparing stainings on wild-type and Sema6A mutant brain sections (Additional file 1). At E17.5, we observed Sema6A-immunopositive corticofugal fibres at the level of the internal capsule and cerebral peduncle (Figure 4b), and positive CST axons at the level of the MHB and pons (Figure 2c). Sema6A was also expressed in the MHB region by the pontine nuclei (Figure 4c–h). By postnatal stage P1, localisation of Sema6A on CST axons was no longer evident, either at the MHB, where expression in the pons persists (Figure 4i–k), or in the medulla, where the inferior olive was strongly Sema6A-immunopositive (Figure 4l–q).
We used in situ RNA hybridization to examine expression of Sema6A, PlxnA2 and PlxnA4 in the neocortex at postnatal stage P4. This revealed laminar and areal-specific staining for each of the three genes (Figure 5). The pattern of layer-specificity is complementary between Sema6A and the Plxn genes in some areas (for example, primary somatosensory cortex (S1)). The laminar patterns also change in an areal-specific manner, especially between S1 and primary motor cortex (M1). Within the primary motor cortex all three genes are expressed to some extent in layer V, the source of CST axons. Sema6A mRNA at these stages is expressed highly in upper layer V, PlxnA2 mRNA has the highest expression throughout layer V, and PlxnA4 mRNA is expressed moderately, also throughout the layer. Corticospinal projection neurons are found predominantly in deep layer V [54, 55]. Consistent with this, and with the lack of antibody staining at this age, staining for PLAP activity in Sema6A heterozygotes does not strongly label CST axons at postnatal stages (data not shown). As PlxnA1 and PlxnA3 have also been indirectly implicated in Sema6A functions [43, 56], though not shown to bind to it directly, we also examined the expression patterns of the genes encoding them in the motor cortex. While both genes are expressed in the cortex at this age, neither is particularly strongly expressed by deep layer V neurons in M1 (Additional file 2).
At the level of the MHB, RNA in situ hybridisation confirmed expression of Sema6A by the pontine nuclei and also by the pontine reticular nuclei (Figure 6). The CST runs between these structures at this point. Just caudally, Sema6A is also expressed by the superior olivary nuclei. PlxnA2 and PlxnA4 are also expressed by the pontine nuclei, in distinct patterns, and by other structures in this region (Figure 6). Just rostral to the level of the pyramidal decussation, Sema6A and PlxnA4 are strongly expressed in the inferior olives at P4, in a partly complementary fashion (Figures 6 and 7). PlxnA2 is weakly expressed in this structure at this age, in a pattern that is very similar to that of PlxnA4. At this point, CST axons are anatomically constrained near the midline by the inferior olives.
As the expression data suggested the possible involvement of the Plxn genes, we investigated further whether similar CST guidance defects can be found in mutants for PlxnA2 and PlxnA4.
Corticospinal tract guidance defects in PlxnA4 but not PlxnA2 mutants
Immunohistochemistry with antibodies against the cell adhesion molecule L1 stains CST fibres selectively at P10. Using this method, we analysed the CST projections in PlxnA2 (n = 3), PlxnA4 (n = 4), and PlxnA2;PlxnA4 double (n = 2) mutants and compared them to Sema6A mutants (n = 2) or normal control mice (Sema6A+/-, n = 1; wild-type, n = 2; PlxnA2+/-, n = 1; PlxnA4+/-, n = 1) (Figure 8).
At the MHB of Sema6A-/- mice at P10, the number of CST axons was already moderately to severely reduced. Only a few misguided axons could be found, indicating that the majority of such axons had already died between P4 and P10. At the decussation level, in some cases virtually no axons were visible. When present at this level, CST axons could be seen either forming a ventrolateral projection, decussating properly or split into two bundles to do both.
PlxnA2-/- mice showed no apparent guidance defects or reduction in size of the CST. In PlxnA4-/- mice, the size of the CST appeared normal from the MHB, where no misguided axons could be found, up to the level of the caudal medulla. Here, the CST split into two bundles that either formed a ventral or ventrolateral projection or decussated normally to join the contralateral dorsal funiculus. This defect, which is fully penetrant, thus strongly resembles that seen in Sema6A mutants.
Double mutants of PlxnA2 and PlxnA4 show very reduced viability and are thus extremely difficult to obtain. We have analysed two double mutants at P10, using anti-L1-immunohistochemistry. These showed no evidence of the defects observed at the level of the MHB and pons in Sema6A mutants (Figure 8). In particular, there was no apparent reduction in the number of fibres passing the pons. The defect in the caudal medulla was essentially the same as that observed in PlxnA4 single mutants. These data suggest that PlxnA2 is not involved in CST guidance in these regions and does not compensate for the lack of PlxnA4 at the MHB.
PlxnA4 mutants do not show guidance defects at the mid-hindbrain boundary or corticospinal tract hypoplasia
To investigate the possibility that misguided axons were not detected at the MHB at P10 in PlxnA4-deficient mice because they might have already died, we traced the CST in these mutants at P4 (Figure 9). The tracing studies confirmed the CST defect at the pyramidal decussation (two of five animals showed no decussating axons, but only ventral projection; three of five mutants showed splitting into decussating and ventrally projecting axons; Figure 9) as described for the anti-L1-staining at P10. We did not find any traced fibres that were misguided at the MHB in PlxnA4 mutants (n = 5 animals, versus PlxnA4+/-, n = 5, and wild-type, n = 2; data not shown).
We describe two independent defects in CST guidance in Sema6A mutants, the first at the MHB, where many CST axons are misrouted and fail to reach the medulla, and the second in the caudal medulla, where many of the remaining axons adopt a ventrolateral position and fail to decussate. Although both PlxnA2 and PlxnA4 are expressed by neurons in deep layer V of motor cortex (the origin of the CST), PlxnA2 mutants do not show any defects in the CST. PlxnA4 mutants show the same phenotype as Sema6A mutants in the caudal medulla but neither PlxnA4 single nor PlxnA2;PlxnA4 double mutants show a defect at the MHB. Expression data suggest that the defect at the MHB may reflect a requirement for expression of Sema6A on CST axons themselves at early embryonic stages. They also implicate the inferior olives as an important source of guidance cues, which act to constrain the CST axons near the midline of the medulla where they can respond to cues for decussation. This model has implications for the interpretation of CST defects observed in other mutants, which we discuss below.
Guidance at the mid-hindbrain boundary
The phenotypes observed in Sema6A mutants identify the MHB as a major choice point, or series of choice points, for CST axons. In fact, CST axons must perform rather complicated manoeuvres to successfully navigate this region and reach the hindbrain. First, exiting the cerebral peduncle at the caudal end of the midbrain, the CST turns sharply from a longitudinal direction towards the midline. Before reaching the midline, it must subsequently turn from this transverse direction ventrally to course over the pons. In parallel, the CST must partially defasciculate to allow collateral branching into the pons while retaining directional projection to reach and refasciculate at the ventral surface of the medulla and form the pyramids. Defects in each of these events can be observed in Sema6A mutants, thus identifying Sema6A as the first guidance molecule controlling CST trajectory at the MHB. Mutations in Ctip2, which encodes a transcription factor expressed in CST neurons, also result in defects at the MHB, where the tract is disorganised and defasciculated, with many axons failing to turn ventrally at the pons and no axons extending past the pons by P0 . While these phenotypes reinforce the notion of this region as a complicated point in the trajectory of CST axons, they are somewhat distinct from those observed in Sema6A mutants.
We see a number of possible scenarios to explain the phenotypes observed. First, Sema6A could act directly in this region in canonical fashion as a repulsive ligand to constrain CST projections to an appropriate channel. This fits generally with the observation that Sema6A expression in this region seems to surround the CST. However, some of the phenotypes, such as midline crossing, are not obviously consistent with this model, given the absence of prominent midline expression of Sema6A. The apparent lack of involvement of the known Plxn receptors might also argue against it. Second, Sema6A could act as an attractive or permissive cue at this level. CST axons project in apposition to a number of pontine nuclei that are strongly Sema6A-positive. Changing responsiveness to guidance cues at different points of an axon's trajectory is a common mechanism , which has been observed directly with semaphorins [58–62]. The importance of Sema6A expression in pontine nuclei is, however, called into question by analyses of mutants in Netrin-1 or its receptor, deleted in colorectal cancer (DCC). In these mice, the pontine nuclei and pontine reticular nuclei fail to condense due to defects in cell migration . While these mice show defects in CST guidance in the hindbrain (see below) they do not show any defects in CST guidance at the MHB. These findings suggest that the phenotype at the MHB in Sema6A mutants may instead be due to a lack of Sema6A expression on CST axons themselves during late embryogenesis. Sema6A could act in CST axons as a receptor for some unknown ligand in surrounding cells or, acting either as a ligand or a receptor (or both), could mediate axon-axon interactions that are important for proper guidance at this level. The orthologous Drosophila gene Sema-1a appears to function in such a fashion in motor axon guidance by setting an appropriate level of fasciculation between motor axons, allowing them to respond to guidance cues at specific choice points .
Our analyses at early postnatal stages indicate that the defects at this point are the most likely cause of the CST hypoplasia observed in adult Sema6A mutants. This is based on several observations: first, in none of the traced mutants did we see a gross difference in the number of CST axons arriving to the MHB at early postnatal stages. Although smaller defects within the forebrain might have been left undetected, we consider this possibility unlikely to be able to account for the significant hypoplasia observed. Second, many CST axons take widely divergent routes at this point and fail to enter the hindbrain. The failure to connect with appropriate targets is likely to result in the degeneration of these axons, which are not detected at later stages, and consequently the death of layer V cells themselves. Indeed, we do not observe any obvious derailed PLAP-stained CST fibres in the MHB region of adult Sema6A mutant brains (data not shown). Third, PlxnA4 mutant mice show similar defects as Sema6A mutants in the caudal medulla, but no defects at the MHB and no hypoplasia of the CST. The later defect within the caudal medulla, which is shared between Sema6A and PlxnA4 mutants, is thus unlikely to contribute to the observed hypoplasia in Sema6A mutants. In fact, many axons that adopt a ventrolateral route within the hindbrain and spinal cord in Sema6A and PlxnA4 mutants persist into adulthood, and have in Sema6A mutants been independently shown to contact appropriate targets in the spinal cord .
Guidance within the medulla
Of the axons that make it to the pyramidal decussation point in Sema6A mutants, some decussate normally and join the dorsal funiculus, while many take up an abnormal ventrolateral position and continue to project caudally on the ipislateral side. The relative proportions of axons that show this phenotype is somewhat variable, in both Sema6A and PlxnA4 mutants. Whether this reflects stochastic variation or some molecular distinction between subtypes of axons is not clear. The CST is thought to be pioneered by a small number of axons, with the majority of axons following these, possibly responding more to fasciculation cues on the surface of these axons than to guidance cues in the environment. Small variations in the number of pioneer axons adopting either of the alternative routes might thus be passively transmitted to the follower axons . While the phenotype is most apparent at the decussation itself, in fact the CST axons begin to spread laterally before this point, that is, at the level of the inferior olive. Sema6A is no longer detected on CST axons at this stage but is strongly expressed in the inferior olives, while PlxnA4 is expressed by the CST neurons. This suggests that Sema6A may normally act as a repulsive cue in the olives to constrain CST axons near the midline (Figure 10). Failure to turn dorsally and cross the midline at the normal decussation point may thus be indirect and simply reflect the fact that these axons are no longer situated in a position to respond to the normal medial cues that promote decussation.
A very similar phenotype has been reported in a number of mutants affecting Netrin signalling . In Unc5c (formerly Unc5h3) mutants, a reduced decussation is observed, with a substantial proportion of axons projecting ventrolaterally. This is preceded in the hindbrain by a lateral broadening of the descending CST, rostral to the level of the decussation. The CST eventually splits into two distinct domains, one close to the midline, which decussates, and one more lateral, which continues to project ipsilaterally. Mutants in netrin-1 and a viable mutant of DCC show similar phenotypes. These were interpreted as evidence for a direct role of Netrin-1, which is expressed at the midline in the region of the decussation, as a guidance factor for CST axons at this choice point . However, the involvement of Unc5c, which normally mediates repulsion from sources of Netrin-1, complicates this interpretation. Our results suggest an alternative model, which is that the decussation defect in CST guidance is secondary to the profound defect in the migration of inferior olivary neurons observed in these mutants . This would be consistent with the lateral broadening of the CST prior to the decussation point in these mutants. Our data suggest that the CST is normally actively hemmed in by the inferior olive, molecularly mediated by Sema6A (Figure 10). If this structure is not formed properly, or if it lacks Sema6A expression, then CST axons will spread laterally and will not decussate properly. (Notably, the olive forms normally in Sema6A mutants.) Interestingly, defects in the formation of the inferior olivary nuclei have also been noted in Joubert syndrome, where pyramidal decussation of the CST also fails to occur [27, 29].
A similar phenotype is observed in NCAM mutants, where a proportion of CST axons adopts a ventrolateral position, while the rest project dorsally and either cross the midline normally or join the ipsilateral dorsal funiculus . In this case, the laterally misrouted axons are detectable at early postnatal stages but do not persist in adults. The cellular basis of this phenotype is not entirely clear; it could involve a disruption of the homophilic fasciculation of follower axons on pioneers or the involvement of NCAM in mediating responses to other guidance cues . In addition, the integrity of the olive in NCAM mutants has not been reported.
Role of plexins
Sema6A has two known binding partners, PlxnA2 and PlxnA4, which have been shown to act as receptors for Sema6A or as antagonists to Sema6A in different contexts [40, 42, 45, 52]. Our expression analyses show that both plexins are expressed in deep layer V of primary motor cortex, the origin of CST axons. Sema6A is expressed on CST axons at early stages but is not detected at perinatal stages, when CST axons are navigating through the hindbrain. At these stages it is expressed more selectively in upper layer V of M1. Analyses of PlxnA2 and PlxnA4 mutants suggest that PlxnA4 is the important player in the guidance of CST axons, while PlxnA2 has no essential function. PlxnA4 mutants show a qualitatively identical phenotype to Sema6A mutants at the level of the pyramidal decussation, although more axons reach that point in PlxnA4 mutants as they do not show any defects at the MHB. An abolished interaction of PlxnA4 and Sema6A is thus sufficient to explain the defect at the decussation choice point. The expression patterns of these molecules favour a classic mode of action in this context; that is, Sema6A acts as a guidance ligand for the receptor PlxnA4. Interestingly, an overlapping role for PlxnA3 in this process has also been demonstrated . These authors observed the presence of ventrolaterally projecting CST axons at low penetrance in either PlxnA3 or PlxnA4 single mutants but at very high penetrance in double mutants. However, PlxnA3 has not been shown to bind Sema6A directly.
Plexins are also well known co-receptors for secreted semaphorins, which have been indirectly implicated in CST axon guidance. As mentioned above, ablation of L1 in mice results in a failure of CST axons to decussate at the caudal medulla and, after correct contralateral or aberrant ipsilateral entry into the dorsal funiculus, to extend down the spinal cord beyond cervical levels . In cortical slice cultures, wild-type but not L1-deficient cortical axons are repelled by Sema3A secreted from the ventral spinal cord and this repulsion requires formation of a co-receptor of L1 and neuropillin-1 (in cis) [61, 68]. In line with this idea, mice expressing L1 with a deleted homophilic binding site that leaves binding to neuropilin-1 intact show a normal CST . However, direct involvement of Sema3A in CST guidance has not been demonstrated. In fact, recent analyses of Sema3A mutant mice did not reveal any CST guidance defects , indicating the involvement of other molecules in L1-mediated CST guidance at the pyramidal decussation. A lack of defects in neuropilin-1 mutant mice  also suggests that transmembrane, rather than secreted semaphorins, may be the major players in vivo in CST guidance and that the phenotypes of Plxn mutants at this choice point reflect their role in direct signalling from transmembrane semaphorins.
The fact that neither the PlxnA2 nor the PlxnA4 single mutants have a CST defect at the MHB suggests either that Sema6A interacts with some other molecule at this choice point or that PlxnA4 and PlxnA2 compensate for each other. Analyses of double mutants of PlxnA2 and PlxnA4 did not reveal any additional defects at the MHB, however. PlxnA3;PlxnA4 double mutants also do not show any defect at the MHB . Though we can not rule out the possible involvement of PlxnA1 at this point , or of additional redundancy between plexins, it seems most likely that the function of Sema6A at this choice point, whether due to expression on the CST axons and/or in the surrounding region, is either homophilic or involves an as yet unknown interacting partner.
Our findings identify Sema6A as a major contributor to the guidance of CST axons at multiple choice points. They highlight the active nature of guidance at the MHB and pons and the possible importance of the inferior olive as a source of guidance information in the hindbrain. PlxnA4 is implicated as a receptor for Sema6A in the hindbrain but the functions of Sema6A at the MHB appear independent of its known interactors, and may be mediated by Sema6A expression in CST axons themselves at this stage. Finally, the involvement of Sema6A in the guidance of CST axons during development has implications for therapeutic approaches to stimulate regeneration of spinal nerves. In particular, the strong expression of Sema6A by oligodendrocytes may contribute substantially to the growth-inhibitory environment of the adult spinal cord [33, 71].
Materials and methods
Animals and histology
Sema6A mutant mice were described previously [18, 53]. Genotyping of Sema6A mice was carried out as described . PlxnA2 and PlxnA4 mutant mice were described in  and , respectively. Staining for expression of the reporter gene PLAP was carried out on 100 μm vibratome sections of adult brains as described .
DiI tracing of the CST
To identify guidance defect of CST axons during development, the tract was traced with the lipophilic fluorescent dye 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI). After sacrificing mice at P4, the skullcap was removed, leaving the brain in the base of the skull, and three DiI crystals were placed unilaterally into the motor cortex (Figure 3c'). The brains were left in phosphate-buffered saline for 3 h and subsequently immersion fixed and kept in phosphate-buffered saline containing 4% paraformaldehyde. After 5 to 7 months, the brains were removed and frontal vibratome sections, 50 μm in thickness, were prepared.
To visualize the CST at P10, immunostaining was carried out on 40 μm vibratome sections using monoclonal rat anti-L1 (1:200; Chemicon, now Millipore, Billerica, MA, USA) or mouse anti L1 (1:500; Abcam, Cambridge, UK) antibodies as described previously . The blocking solution contained 1% bovine serum albumin, 5% normal serum, and 0.5% Triton-100. Primary antibody was visualized with Cy2- or Cy3-conjugated anti-rat or -mouse IgG (Jackson ImmunoResearch, West Grove, PA, USA). For protein expression analysis at E17.5 and P1, we used goat anti mouse Sema6A (1:100; R&D Systems, Abingdon, UK) together with mouse anti-neurofilament-M (clone 2H3, 1:50; DSHB, University of Iowa, Iowa City, USA) as a reference staining of fibres using the same protocol except for an initial 30 minute incubation of sections in 20 mM sodium citrate, pH8.5 at 80°C for antigen retrieval.
RNA in situ hybridization
In situ hybridization was performed on free-floating 50 μm vibratome sections of P1 and P4 brains, as previously described . The following digoxigenin-labeled RNA probes were used: Sema6A (kind gift of W Snider), PlxnA2 and PlxnA4 (from the lab of M Tessier-Lavigne).
primary motor cortex
placental alkaline phosphatase
primary somatosensory cortex.
Canty AJ, Murphy M: Molecular mechanisms of axon guidance in the developing corticospinal tract. Prog Neurobiol. 2008, 85: 214-235.
Tissir F, Bar I, Jossin Y, De Backer O, Goffinet AM: Protocadherin Celsr3 is crucial in axonal tract development. Nat Neurosci. 2005, 8: 451-457.
Zhou L, Bar I, Achouri Y, Campbell K, De Backer O, Hebert JM, Jones K, Kessaris N, de Rouvroit CL, O'Leary D, Richardson WD, Goffinet AM, Tissir F: Early forebrain wiring: genetic dissection using conditional Celsr3 mutant mice. Science. 2008, 320: 946-949.
Wang Y, Zhang J, Mori S, Nathans J: Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling. J Neurosci. 2006, 26: 355-364.
Wang Y, Thekdi N, Smallwood PM, Macke JP, Nathans J: Frizzled-3 is required for the development of major fiber tracts in the rostral CNS. J Neurosci. 2002, 22: 8563-8573.
Jones L, Lopez-Bendito G, Gruss P, Stoykova A, Molnar Z: Pax6 is required for the normal development of the forebrain axonal connections. Development. 2002, 129: 5041-5052.
Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD: Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron. 2005, 45: 207-221.
Marin O, Baker J, Puelles L, Rubenstein JL: Patterning of the basal telencephalon and hypothalamus is essential for guidance of cortical projections. Development. 2002, 129: 761-773.
Bagri A, Marin O, Plump AS, Mak J, Pleasure SJ, Rubenstein JL, Tessier-Lavigne M: Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain. Neuron. 2002, 33: 233-248.
Lopez-Bendito G, Flames N, Ma L, Fouquet C, Di Meglio T, Chedotal A, Tessier-Lavigne M, Marin O: Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain. J Neurosci. 2007, 27: 3395-3407.
Dahme M, Bartsch U, Martini R, Anliker B, Schachner M, Mantei N: Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat Genet. 1997, 17: 346-349.
Cohen NR, Taylor JS, Scott LB, Guillery RW, Soriano P, Furley AJ: Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr Biol. 1998, 8: 26-33.
Runker AE, Bartsch U, Nave KA, Schachner M: The C264Y missense mutation in the extracellular domain of L1 impairs protein trafficking in vitro and in vivo. J Neurosci. 2003, 23: 277-286.
Dottori M, Hartley L, Galea M, Paxinos G, Polizzotto M, Kilpatrick T, Bartlett PF, Murphy M, Kontgen F, Boyd AW: EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract. Proc Natl Acad Sci USA. 1998, 95: 13248-13253.
Helmbacher F, Schneider-Maunoury S, Topilko P, Tiret L, Charnay P: Targeting of the EphA4 tyrosine kinase receptor affects dorsal/ventral pathfinding of limb motor axons. Development. 2000, 127: 3313-3324.
Kullander K, Croll SD, Zimmer M, Pan L, McClain J, Hughes V, Zabski S, DeChiara TM, Klein R, Yancopoulos GD, Gale NW: Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control. Genes Dev. 2001, 15: 877-888.
Kullander K, Mather NK, Diella F, Dottori M, Boyd AW, Klein R: Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo. Neuron. 2001, 29: 73-84.
Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P, Skarnes WC, Tessier-Lavigne M: Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature. 2001, 410: 174-179.
Rolf B, Bastmeyer M, Schachner M, Bartsch U: Pathfinding errors of corticospinal axons in neural cell adhesion molecule-deficient mice. J Neurosci. 2002, 22: 8357-8362.
Finger JH, Bronson RT, Harris B, Johnson K, Przyborski SA, Ackerman SL: The netrin 1 receptors Unc5h3 and Dcc are necessary at multiple choice points for the guidance of corticospinal tract axons. J Neurosci. 2002, 22: 10346-10356.
Depienne C, Stevanin G, Brice A, Durr A: Hereditary spastic paraplegias: an update. Curr Opin Neurol. 2007, 20: 674-680.
Reid E: Many pathways lead to hereditary spastic paraplegia. Lancet Neurol. 2003, 2: 210-
Fransen E, Vits L, Van Camp G, Willems PJ: The clinical spectrum of mutations in L1, a neuronal cell adhesion molecule. Am J Med Genet. 1996, 64: 73-77.
Kamiguchi H, Hlavin ML, Lemmon V: Role of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci. 1998, 12: 48-55.
Louie CM, Gleeson JG: Genetic basis of Joubert syndrome and related disorders of cerebellar development. Hum Mol Genet. 2005, 14 (Spec No. 2): R235-242.
Harris PC: Genetic complexity in Joubert syndrome and related disorders. Kidney Int. 2007, 72: 1421-1423.
Friede RL, Boltshauser E: Uncommon syndromes of cerebellar vermis aplasia. I: Joubert syndrome. Dev Med Child Neurol. 1978, 20: 758-763.
Maria BL, Boltshauser E, Palmer SC, Tran TX: Clinical features and revised diagnostic criteria in Joubert syndrome. J Child Neurol. 1999, 14: 583-590. discussion 590–591.
Yachnis AT, Rorke LB: Neuropathology of Joubert syndrome. J Child Neurol. 1999, 14: 655-659. discussion 669–672.
Ferland RJ, Eyaid W, Collura RV, Tully LD, Hill RS, Al-Nouri D, Al-Rumayyan A, Topcu M, Gascon G, Bodell A, Shugart YY, Ruvolo M, Walsh CA: Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat Genet. 2004, 36: 1008-1013.
Poretti A, Boltshauser E, Loenneker T, Valente EM, Brancati F, Il'yasov K, Huisman TA: Diffusion tensor imaging in Joubert syndrome. AJNR Am J Neuroradiol. 2007, 28: 1929-1933.
Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, James S, Voets N, Watkins K, Matthews PM, James A: Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain. 2007, 130: 2375-2386.
Yaron A, Zheng B: Navigating their way to the clinic: Emerging roles for axon guidance molecules in neurological disorders and injury. Dev Neurobiol. 2007, 67: 1216-1231.
Jakeman LB, Chen Y, Lucin KM, McTigue DM: Mice lacking L1 cell adhesion molecule have deficits in locomotion and exhibit enhanced corticospinal tract sprouting following mild contusion injury to the spinal cord. Eur J Neurosci. 2006, 23: 1997-2011.
Chen J, Wu J, Apostolova I, Skup M, Irintchev A, Kugler S, Schachner M: Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury. Brain. 2007, 130: 954-969.
Chen J, Bernreuther C, Dihne M, Schachner M: Cell adhesion molecule l1-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. J Neurotrauma. 2005, 22: 896-906.
Fabes J, Anderson P, Brennan C, Bolsover S: Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord. Eur J Neurosci. 2007, 26: 2496-2505.
Yazdani U, Terman JR: The semaphorins. Genome Biol. 2006, 7: 211-
Mann F, Chauvet S, Rougon G: Semaphorins in development and adult brain: Implication for neurological diseases. Prog Neurobiol. 2007, 82: 57-79.
Suto F, Ito K, Uemura M, Shimizu M, Shinkawa Y, Sanbo M, Shinoda T, Tsuboi M, Takashima S, Yagi T, Fujisawa H: Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci. 2005, 25: 3628-3637.
Yoshida Y, Han B, Mendelsohn M, Jessell TM: PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord. Neuron. 2006, 52: 775-788.
Bron R, Vermeren M, Kokot N, Andrews W, Little GE, Mitchell KJ, Cohen J: Boundary cap cells constrain spinal motor neuron somal migration at motor exit points by a semaphorin-plexin mechanism. Neural Develop. 2007, 2: 22-
Mauti O, Domanitskaya E, Andermatt I, Sadhu R, Stoeckli ET: Semaphorin6A acts as a gate keeper between the central and the peripheral nervous system. Neural Develop. 2007, 2: 28-
Kerjan G, Dolan J, Haumaitre C, Schneider-Maunoury S, Fujisawa H, Mitchell KJ, Chedotal A: The transmembrane semaphorin Sema6A controls cerebellar granule cell migration. Nat Neurosci. 2005, 8: 1516-1524.
Suto F, Tsuboi M, Kamiya H, Mizuno H, Kiyama Y, Komai S, Shimizu M, Sanbo M, Yagi T, Hiromi Y, Chédotal A, Mitchell KJ, Manabe T, Fujisawa H: Interactions between Plexin-A2, Plexin-A4, and Semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers. Neuron. 2007, 53: 535-547.
Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Suto F, Kamei J, Aoki K, Yabuki M, Hori M, Fujisawa H, Kikutani H: Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev. 2004, 18: 435-447.
Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Yabuki M, Harada K, Hori M, Kikutani H: Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol. 2004, 6: 1204-1211.
Zhou Y, Gunput RA, Pasterkamp RJ: Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci. 2008, 33: 161-170.
Godenschwege TA, Hu H, Shan-Crofts X, Goodman CS, Murphey RK: Bi-directional signaling by Semaphorin 1a during central synapse formation in Drosophila. Nat Neurosci. 2002, 5: 1294-1301.
Komiyama T, Sweeney LB, Schuldiner O, Garcia KC, Luo L: Graded expression of semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons. Cell. 2007, 128: 399-410.
Cafferty P, Yu L, Long H, Rao Y: Semaphorin-1a functions as a guidance receptor in the Drosophila visual system. J Neurosci. 2006, 26: 3999-4003.
Renaud J, Kerjan G, Sumita I, Zagar Y, Georget V, Kim D, Fouquet C, Suda K, Sanbo M, Suto F, Ackerman SL, Mitchell KJ, Fujisawa H, Chédotal A: Plexin-A2 and its ligand, Sema6A, control nucleus-centrosome coupling in migrating granule cells. Nat Neurosci. 2008, 11: 440-449.
Mitchell KJ, Pinson KI, Kelly OG, Brennan J, Zupicich J, Scherz P, Leighton PA, Goodrich LV, Lu X, Avery BJ, Tate P, Dill K, Pangilinan E, Wakenight P, Tessier-Lavigne M, Skarnes WC: Functional analysis of secreted and transmembrane proteins critical to mouse development. Nature Genet. 2001, 28: 241-249.
Hevner RF, Daza RA, Rubenstein JL, Stunnenberg H, Olavarria JF, Englund C: Beyond laminar fate: toward a molecular classification of cortical projection/pyramidal neurons. Dev Neurosci. 2003, 25: 139-151.
Gao WJ, Zheng ZH: Target-specific differences in somatodendritic morphology of layer V pyramidal neurons in rat motor cortex. J Comp Neurol. 2004, 476: 174-185.
Faulkner RL, Low LK, Liu XB, Coble J, Jones EG, Cheng HJ: Dorsal turning of motor corticospinal axons at the pyramidal decussation requires plexin signaling. Neural Develop. 2008, 3: 21-
Yu TW, Bargmann CI: Dynamic regulation of axon guidance. Nat Neurosci. 2001, 4 (Suppl): 1169-1176.
Zou Y, Stoeckli E, Chen H, Tessier-Lavigne M: Squeezing axons out of the gray matter: a role for slit and semaphorin proteins from midline and ventral spinal cord. Cell. 2000, 102: 363-375.
Bechara A, Falk J, Moret F, Castellani V: Modulation of semaphorin signaling by Ig superfamily cell adhesion molecules. Adv Exp Med Biol. 2007, 600: 61-72.
Chauvet S, Cohen S, Yoshida Y, Fekrane L, Livet J, Gayet O, Segu L, Buhot MC, Jessell TM, Henderson CE, Mann F: Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron. 2007, 56: 807-822.
Castellani V, De Angelis E, Kenwrick S, Rougon G: Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. EMBO J. 2002, 21: 6348-6357.
Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, Poo M: Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides [see comments]. Science. 1998, 281: 1515-1518.
Yee KT, Simon HH, Tessier-Lavigne M, O'Leary DM: Extension of long leading processes and neuronal migration in the mammalian brain directed by the chemoattractant netrin-1. Neuron. 1999, 24: 607-622.
Yu HH, Huang AS, Kolodkin AL: Semaphorin-1a acts in concert with the cell adhesion molecules fasciclin II and connectin to regulate axon fasciculation in Drosophila. Genetics. 2000, 156: 723-731.
Mitchell KJ: The genetics of brain wiring: from molecule to mind. PLoS Biol. 2007, 5: e113-
Bloch-Gallego E, Ezan F, Tessier-Lavigne M, Sotelo C: Floor plate and netrin-1 are involved in the migration and survival of inferior olivary neurons. J Neurosci. 1999, 19: 4407-4420.
Ditlevsen DK, Povlsen GK, Berezin V, Bock E: NCAM-induced intracellular signaling revisited. J Neurosci Res. 2008, 86: 727-743.
Castellani V, Chedotal A, Schachner M, Faivre-Sarrailh C, Rougon G: Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. Neuron. 2000, 27: 237-249.
Itoh K, Cheng L, Kamei Y, Fushiki S, Kamiguchi H, Gutwein P, Stoeck A, Arnold B, Altevogt P, Lemmon V: Brain development in mice lacking L1-L1 homophilic adhesion. J Cell Biol. 2004, 165: 145-154.
Sibbe M, Taniguchi M, Schachner M, Bartsch U: Development of the corticospinal tract in Semaphorin3A- and CD24-deficient mice. Neuroscience. 2007, 150: 898-904.
Pasterkamp RJ, Verhaagen J: Emerging roles for semaphorins in neural regeneration. Brain Res Brain Res Rev. 2001, 35: 36-54.
Dolan J, Walshe K, Alsbury S, Hokamp K, O'Keeffe S, Okafuji T, Miller SF, Tear G, Mitchell KJ: The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics. 2007, 8: 320-
We are very grateful to Jackie Dolan for technical assistance with genotyping and to her and Mary Phillips for help with mouse breeding. We thank Marc Tessier-Lavigne and colleagues for the gift of Plxn in situ probes and William Snider for the Sema6A probe. We also thank Hwai-Jong Cheng and colleagues for communicating unpublished data and for very useful discussions. We are very grateful to Marius Ader for generous help with microscopy. This work was supported by grants from Science Foundation Ireland (01/F1/B006) to KJM and a postdoctoral fellowship from the Health Research Board to AER (PD/2004/16). GEL has been supported by a Government of Ireland Scholarship, awarded by the Irish Research Council of Science, Engineering and Technology. HF was supported by the 21st Century Centers of Excellence Program and Grants-in-Aid for Scientific Research Japan. FS was supported by grants from CREST of the Japanese Science and Technology Agency.
The authors declare that they have no competing interests.
AER designed and performed experiments, analysed data, and wrote the paper. GEL designed and performed experiments, and analysed data. FS provided reagents and samples. HF provided reagents and samples. KJM designed experiments, analysed data, and wrote the paper.
Electronic supplementary material
Additional file 1: Specificity of the goat anti-mouse Sema6A antibody. Sema6A immunohistochemistry on E17.5 coronal (a, b, d-g) and P0 sagittal (c) brain sections of Sema6A homozygous mutant (S6A-/-) (a, d, f) and wild-type (wt) (b, c, e, g) mice. The Sema6A antibody binds specifically to the deeper part of the external granule cell layer (EGL in (c), asterisk in (b)) of the cerebellum of E17.5 (b) and P0 (c) wild-type mice, as described previously , but not to the EGL in Sema6A mutants (a) (asterisk). In these mutants, the antibody detects the mutated Sema6A protein [18, 65], which is located only in cell bodies in all brain regions investigated, such as granule cells of the cerebellum (a) or in cells that form the inferior olive (IO) of the medulla (d). Note that in the mutants, the corticospinal tract (CST) (f) is not stained, which is in contrast to that of wild type (g). IGL, internal granule cell layer. Scale bars 100 μm: the scale bar in (b) is for (a, b); the scale bar in (g) is for (c-g). (TIFF 11 MB)
Additional file 2: Expression of PlxnA1 and PlxnA3 in motor cortex. In situ hybridization on coronal brain sections of P4 wild-type mice at low (a, c) and higher (b, d) magnification. Within the primary motor cortex (M1), PlxnA1 is only moderately expressed throughout layers, but lowest in layers V and VI. In this area PlxnA3 is expressed at moderate to strong levels in upper layers, but only moderately in lower layers. Scale bar in (c) is 200 μm and is for (a, c); scale bar in (d) is 100 μm and is for (b, d). (TIFF 7 MB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Rünker, A.E., Little, G.E., Suto, F. et al. Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. Neural Dev 3, 34 (2008) doi:10.1186/1749-8104-3-34
- Inferior Olive
- Choice Point
- Pontine Nucleus
- Joubert Syndrome
- Dorsal Funiculus